Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel

Molnupiravir (MOV) was introduced in Israel in January 2022 during the SARS-CoV-2 Omicron surge for high-risk patients contraindicated for nirmatrelvir/ritonavir. This retrospective cohort study aimed to describe characteristics of patients offered COVID-19 antiviral treatment in Maccabi Healthcare...

Full description

Saved in:
Bibliographic Details
Main Authors: Clara Weil (Author), Tobias Bergroth (Author), Anna Eisenberg (Author), Yohance Omar Whiteside (Author), Yoseph Caraco (Author), Lilac Tene (Author), Gabriel Chodick (Author)
Format: Book
Published: MDPI AG, 2023-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items